Alexion’s (ALXN) Earnings Beat Estimates in Q4, Shares Up
Alexion Pharmaceuticals, Inc . ALXN posted fourth-quarter 2018 adjusted earnings of $2.14 per share, which increased 45% from the year-ago quarter’s $1.48. Earnings also beat the Zacks Consensus Estimate of $1.83 […]